Nothing suspicious here!
/s
OBJECTIONS RAISED BY SCIENTISTS TO THE LANCET STUDY:
* One of the main concerns was a lack of information about the countries and hospitals that contributed to the data, which was provided by Chicago-based healthcare data analytics firm Surgisphere.
* The authors also list implausible ratios of use of the drugs in some continents and discrepancies in the data for Australia, where they said there were more deaths recorded in the hospitals covered by the study than official figures for the entire country.
* Surgisphere (the data company) have since stated this was an error of classification of one hospital from Asia. This indicates the need for further error checking throughout the database,
SIGNATORIES TO THE LETTER EXPRESSING CONCERN:
Clinicians, epidemiologists and other researchers from around the world, from Harvard to Imperial College London.